About Us

We are an established life-sciences venture capital firm with a long track record of consistent returns investing in best/first-in-class European Biopharma and HealthTech companies

Our seasoned team of domain experts possesses investment expertise, a deep scientific understanding of the life sciences field, and the passion to build companies. We work closely with ambitious entrepreneurs and invest progressively in the development of our portfolio companies. We thoughtfully build a diversified portfolio by indication, stage, technology and geography across Europe. We finance both early stage companies and corporate spin-offs with more mature assets, focusing on two life sciences themes:

HealthTech

Advances in digital technology are revolutionizing the healthcare…

Better
diagnosis
 

Improved patient
outcomes

Reduced
costs

Investment stage: early commercialization and growth

Biopharma

First-in-class and best-in-class drugs are the backbone
of innovation in healthcare

Novel
targets

Focus on
unmet needs

New chemical
entities, biologics,
advanced therapies

Investment stage: late pre-clinical / early clinical and growth

We completed our First Closing and continue to fund raise for Fund IV Final Close

€150M+

fund

10-12

deals

€10-15M

per deal

50-70%

reserved for follow investments

90%

lead / co-lead investor